9Lun·

Purchases this week

I'll cautiously set foot in the door at $GSIT a cautious foot in the door. Here, however, profit-taking could encourage better entries (for additional buying).

In addition to my Nektar $NKTR (-5,41 %) position, I want to expand my biotech/health field. With Tempus $TEM (-7,46 %) and the @BamBamInvest value Procept $PRCT.

05.01
GSI Technology logo
Comprado a 6,73 US$
6
6 Comentarios

Imagen de perfil
Apart from $GSIT, I have them all.
•
1
•
Imagen de perfil
@Multibagger nectar, I'm really excited. It's almost an all or nothing bet. If the 52-week study disappoints, you have to win the lawsuit against Eli Lilly for a second Versuch😵‍💫 but I'm in good spirits
•
1
•
Imagen de perfil
@Darkwingduck I think it will at least double this year.
••
Imagen de perfil
@Multibagger If the study is good, then Lutzi will really take off. They will then enter markets worth several billion euros (Dupixent, Rinvoq).
•
1
•
Imagen de perfil
@Multibagger Have you heard of $LCTX? They've partnered with Roche $ROG for their studies.
•
1
•
Imagen de perfil
@Darkwingduck never heard
••
Únase a la conversación